regadenoson has been researched along with Left Ventricular Dysfunction in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Erinne, I; Kempf, J | 1 |
Fish, MB; Lemley, M; Miller, RJH; Otaki, Y; Slomka, PJ | 1 |
Ali, B; Ali, T; Blankstein, R; Bruyere, J; Di Carli, MF; Dorbala, S; Hsiao, E; Kwong, RY; Skali, H | 1 |
Nichols, KJ; Palestro, CJ; Reichek, N; Van Tosh, A; Votaw, JR | 1 |
Bateman, TM; Cerqueira, MD; Iskandrian, AE; Mahmarian, JJ; Nabi, F; Peterson, LE; Thomas, GS; Xu, J | 1 |
Jaber, WA; Kerrigan, J; Sabik, EM; Shivapour, D; Tuzcu, EM | 1 |
Berman, D; Brodov, Y; Fish, M; Gerlach, J; Germano, G; Gransar, H; Lemley, M; Otaki, Y; Rubeaux, M; Slomka, P | 1 |
Bateman, TM; Cerqueira, MD; Hendel, RC; Iskandrian, AE; Mahmarian, JJ; Moye, LA; Olmsted, AW; Thomas, GS | 1 |
Dean, P; Hage, FG; Heo, J; Iqbal, F; Iskandrian, AE | 1 |
2 trial(s) available for regadenoson and Left Ventricular Dysfunction
Article | Year |
---|---|
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Coronary Artery Disease; Double-Blind Method; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2015 |
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
Topics: Adenosine; Coronary Artery Disease; Coronary Circulation; Double-Blind Method; Heart Ventricles; Humans; Infusions, Intravenous; Linear Models; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Severity of Illness Index; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
7 other study(ies) available for regadenoson and Left Ventricular Dysfunction
Article | Year |
---|---|
Incidental Detection of Locally Progressed Pancreatic Cancer on SPECT Myocardial Perfusion Images.
Topics: Aged, 80 and over; Bile Ducts; Dilatation; Disease Progression; Echocardiography; Humans; Incidental Findings; Liver; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Pancreatic Neoplasms; Perfusion; Purines; Pyrazoles; Syncope; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
Prognostic value of early left ventricular ejection fraction reserve during regadenoson stress solid-state SPECT-MPI.
Topics: Humans; Male; Prognosis; Purines; Pyrazoles; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Humans; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Rubidium Radioisotopes; Stress, Physiological; Stroke Volume; Tomography, X-Ray Computed; Vasodilator Agents; Ventricular Dysfunction, Left | 2013 |
The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated (82)Rb PET myocardial perfusion imaging.
Topics: Aged; Coronary Angiography; Coronary Circulation; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Rubidium Radioisotopes; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Acute left ventricular dys-synchrony during regadenason PET myocardial perfusion stress test.
Topics: Acute Disease; Exercise Test; Female; Humans; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Radiopharmaceuticals; Rubidium Radioisotopes; Vasodilator Agents; Ventricular Dysfunction, Left | 2015 |
Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99m high-efficiency SPECT.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2016 |
A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.
Topics: Adenosine A2 Receptor Antagonists; Alabama; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2011 |